MilliporeSigma Webinars

  1. PAT Implementation For ADC And Bioconjugation Processes 3/1/2024

    Explore expert insights into the implementation of Process Analytical Technology (PAT) for ADC and bioconjugation processes and the pros and cons of in(on)line testing for the conjugation process.

  2. Advancements In Process And Payload Development 2/29/2024

    Continuous advancements in the process and payload development of ADCs and next-generation bioconjugates have the potential to progress targeted therapeutics and improve patient treatment options.

  3. The Closed Processing Advantage: Optimizing Biopharma Facilities 11/16/2023

    Explore the evolving landscape of biopharma facility design and operations, including key market trends, closed processing benefits, and industry efforts to harmonize guidance and best practices.

  4. Accelerated Monoclonal Antibody Development 9/26/2023

    Hear from some of the experts who were instrumental in developing the Accelerated mAb development program and work with biotech companies on a daily basis to accelerate their production timelines.

  5. From Myth To Mastery: Unveiling The Secrets Of Virus Bank Manufacturing 9/12/2023

    It is crucial to start off your product development right. Here, you will learn how to best approach virus bank production. Review best practices, how to overcome common obstacles, and more.

  6. Kick It Off Right: A Successful Cell Bank Manufacture 9/12/2023

    Learn about best practices for cell bank manufacturing, how to get the most out of your cell bank, the future of closed processing in line with Annex 1, and more.

  7. Characterizing AAV Encapsidated Nucleic Acid Sequences Using NGS 8/11/2023

    Here, we discuss the characterization of several representative AAV molecules using next-generation sequencing (NGS), including the sequencing process, bioinformatic analysis, and representative results.

  8. Maximizing The Value Of Your AAV Using Small Volume AAV Testing 8/11/2023

    Learn about an approach to method development, where more than one AAV critical quality attribute can be measured within a single analytical run.

  9. A Single-Use, Scale-Down, Predictive Solution For Intensified Perfusion Development 6/23/2023

    Here, we describe a new microbioreactor system that fulfills the throughput-performance gap, providing single-use, perfusion bioreactors that can replicate bench-scale perfusion processes at industrially relevant cell densities.

  10. Key Benefits Of PCR-Based mRNA Manufacturing For Clinical Development 6/12/2023

    To unlock the potential of your mRNA therapies and accelerate your development and manufacturing program, discover the benefits of a novel PCR-based mRNA drug substance manufacturing process.